Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Testing Strength Measures in People With Heart Conditions or Risk Factors

Compares two strength tests that estimate maximum lifting ability in people with heart disease.

Plain-language title generated from the registry record
Registry title: Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors

Key facts

Where
München, GermanySee the site

Where in Germany

  • Department for Preventive Sports Medicine and Sports Cardiology, TUM Klinikum Rechts der Isar, Technical University of MunichMünchen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Technical University of Munich
Trial code
NCT06796582
Record updated
22 October 2026
Original description
Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).Read full original descriptionShow less

Agreement of the Estimated 1-Repetition-Maximum Between Two Multiple-Repetition-Maximum Tests With Different Weight in Patients With Cardiovascular Disease or Risk Factors

Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).

Inclusion: Age ≥ 50 years; At least one of the following cardiovascular diseases / risk factors:; Heart failure; Coronary heart disease; Atrial fibrillation; Arterial hypertension; Type 2 diabetes mellitus; Clinically stable for ≥ 4 weeks; Medical clearance to perform resistance training / strength testing; Signed written informed consent.

Exclusion: Acute infection; Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic); Pregnancy; Chronic joint inflammation; Knee, hip, ankle, wrist, elbow or shoulder pain; Known osteoporosis (T-value ≤ -2.5); Known cerebral or thoracic aneurysm.

ClinicalTrials.gov NCT06796582